EGFR exon 20 insertion mutation in advanced thymic squamous cell carcinoma: Response to apatinib and clinical outcomes.

about

EGFR exon 20 insertion mutation in advanced thymic squamous cell carcinoma: Response to apatinib and clinical outcomes.

Item

http://www.wikidata.org/entity/Q55516288

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

EGFR exon 20 insertion mutatio ...... patinib and clinical outcomes.

@en

EGFR exon 20 insertion mutatio ...... patinib and clinical outcomes.

@nl

type

Item

label

EGFR exon 20 insertion mutatio ...... patinib and clinical outcomes.

@en

EGFR exon 20 insertion mutatio ...... patinib and clinical outcomes.

@nl

prefLabel

EGFR exon 20 insertion mutatio ...... patinib and clinical outcomes.

@en

EGFR exon 20 insertion mutatio ...... patinib and clinical outcomes.

@nl

P1476

EGFR exon 20 insertion mutatio ...... patinib and clinical outcomes.

@en

P2093

Chen Jinliang

http://www.w3.org/2001/XMLSchema#string

Lin Li

http://www.w3.org/2001/XMLSchema#string

Meng Zhaoting

http://www.w3.org/2001/XMLSchema#string

Su Yudong

http://www.w3.org/2001/XMLSchema#string

Wang Xinyue

http://www.w3.org/2001/XMLSchema#string

Xu Xiaoyan

http://www.w3.org/2001/XMLSchema#string

Zuo Ran

http://www.w3.org/2001/XMLSchema#string

P2860

Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy.

Thymic tumors: relevant molecular data in the clinic.

Comparison of patterns of relapse in thymic carcinoma and thymoma.

Epidemiology of thymoma and associated malignancies.

PD-1/PD-L1 inhibitors.

Outcome of nonsurgical treatment for locally advanced thymic tumors

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.

Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy.

Antiangiogenic therapy in oncology: current status and future directions.

Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice.

P304

885-891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1111/1759-7714.12755

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chen Peng

P577

2018-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29740957

http://www.w3.org/2001/XMLSchema#string

P932

6026601

http://www.w3.org/2001/XMLSchema#string